Condition
KRAS Mutation-Related Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 3 KRAS Mutation-Related Tumors clinical trials that are recruiting, at sites in 10 countries (most in United States (3), Australia (1), China (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 10Countries
Newest KRAS Mutation-Related Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Single-protein encapsulated doxorubicin (SPEDOX-6) for advanced solid tumors | Phase 1/2 | Orange, California | Recruiting | Jul 14, 2025 |
| Evaluating BDTX-4933 for patients with specific cancer mutations | Phase 1/2 | Gilbert, Arizona and 48 other locations | Recruiting | Mar 28, 2023 |
| Combining NEROFE and Doxorubicin for KRAS-mutated Solid Tumors | Phase 1 | Washington D.C., District of Columbia | Recruiting | Dec 22, 2022 |
All recruiting trials (3)
-
Single-protein encapsulated doxorubicin (SPEDOX-6) for advanced solid tumors
We will try SPEDOX-6, a protein-encapsulated form of doxorubicin, to find a safe dose and see if it helps adults with advanced, treatment-resistant solid tumors (including certain sarcomas, triple-negative breast cancer, non-small cell lung cancer, cervical, ovarian, and KRAS‑mutant pancreatic cancers) who have not rec
-
Evaluating BDTX-4933 for patients with specific cancer mutations
This study is testing a new drug called BDTX-4933 to see if it can help adults with advanced cancers that have certain gene mutations feel better and improve their treatment options.
-
Combining NEROFE and Doxorubicin for KRAS-mutated Solid Tumors
This study is testing if a new treatment called NEROFE, when combined with the cancer drug doxorubicin, can help people with advanced solid tumors that have a KRAS mutation and haven't responded to other treatments.
Related topics
Quick answers
How many KRAS Mutation-Related Tumors clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), Australia (1 trial), China (1 trial), Denmark (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.